Sarcopenia-related gut microbiota in the elderly: Insights from the longevity region of Kyotango and its nutritional associations Authors: Takeshi Yasuda, Tomohisa Takagi, Yuji Naito, Ryo Inoue, Katsura Mizushima, Kouhei Asaeda, Hikaru Hashimoto, Hiroaki Kitae, Kazuhiko Uchiyama, Norihiro Ouchi, Atsuo Adachi, Tadaaki Kamitani, Satoaki Matoba, Yoshito Itoh Published: 2025 ABSTRACT AbstractSarcopenia is influenced by the gut microbiota and dietary habits; however, the underlying mechanisms remain elusive. This study investigated the gut microbiota composition of elderly individuals in a healthy longevity region and examined its association with sarcopenia and dietary habits. Fecal metagenomic analysis was used to identify gut microbiota taxonomy. Sarcopenia was diagnosed on the basis of grip strength, gait speed, and muscle volume. Japanese dietary habits were assessed using a brief-type self-administered diet history questionnaire. A total of 318 elderly individuals from Kyotango were recruited, 5.7% of whom were diagnosed with sarcopenia. Individuals with sarcopenia exhibited a lower abundance of a genus belonging to the family Lachnospiraceae, and a higher abundance of Megasphera. Several butyrate-producing bacteria, including Lachnospira and Coprococcus showed a positive correlation with sarcopenia related factors, whereas Dorea and Streptococcus were negatively correlated. Hierarchical cluster analysis revealed that these beneficial genera were also positively associated with the frequent intake of traditional Japanese dietary components. These findings suggest that the observed microbial and dietary associations may provide a mechanistic basis for potential protective effects against sarcopenia. Our findings suggest that butyrate-producing bacteria associated with Japanese dietary patterns play a protective role against sarcopenia.Keywords: Sarcopenia, gut microbiota, Japanese dietary culture, Japanese diet index, butyrate-producing bacteria Introduction In recent years, the global population has experienced an accelerated aging trend. Specifically, the Japanese mean lifetime consistently ranks among the world's highest and continues to increase annually. Nevertheless, healthy life expectancy has not increased.1 The causes of this gap include sarcopenia, unhealthy dietary habits, hypertension, smoking, obesity, and diabetes.2‐5 Sarcopenia is typically diagnosed using muscle strength indicators, such as grip strength and gait speed, in addition to total body skeletal muscle volume.6 A Japanese cohort study on the general elderly population published in 2021 showed that the prevalence of sarcopenia was 11.5% in men and 16.7% in women.7 The prevalence of sarcopenia increases with age; approximately 22% of men and women in the 75–79 age group and 32% of men and 48% of women over 80 years of age have sarcopenia. Notably, sarcopenia has been shown to increase the risk of both death and long-term care by approximately two-fold, thereby undermining healthy longevity.7 However, the pathogenesis of sarcopenia is complex and yet to be elucidated. The association between sarcopenia and the gut microbiota has been reported in recent years.8‐11 A systematic review of the relationship between gut microbiota, muscle volume, and physical performance suggested that a decrease in butyrate-producing bacteria, such as Clostridium XIVa and Roseburia, promotes anabolic resistance and chronic inflammation, which may be associated with muscle atrophy.8 Another study also demonstrated that several butyrate producers, including Lachnospira, Prevotella, Ruminococcus, and Clostridium, were reduced in individuals with sarcopenia.9,10 Furthermore, Han et al. reported that elderly people with decreased muscle mass exhibited a lower proportion of Bacillota compared to Bacteroidota.11 Daily dietary habits also influence sarcopenia onset. The Mediterranean diet, which is known to promote health and longevity, is associated with a lower incidence of sarcopenia among individuals who consume it frequently.12 Similar to the Mediterranean diet in Europe, the traditional Japanese diet is known for its emphasis on healthy food.13 A previous study investigated the relationship between the frequency of Japanese diet consumption and grip strength 14 and found that individuals with a decline in grip strength tended to consume the Japanese diet less frequently. The Kyotango area (Kyotango City, Miyazu City, Yosano Town, and Ine Town, located in the northernmost part of Kyoto Prefecture) is a region with traditional Japanese dietary culture. This region has gained attention as the healthiest and longest-living area in Japan.15 In the Kyotango area, the ratio of centenarians is approximately three times the national average (per 100,000 people) (as of March 2020, the Japanese Basic Resident Ledger). The longevity of residents in this area has been suggested to be attributed to the prevalent Japanese dietary culture. Interestingly, the residents of this region have a higher prevalence of butyrate-producing bacteria in their intestines than residents of urban areas.15 While previous studies have reported an association between reduced butyrate-producing bacteria and sarcopenia,8‐10 few have focused on cohorts from longevity regions with distinctive traditional dietary habits. In particular, there is a lack of research investigating how dietary patterns unique to the Japanese culture may influence the abundance of specific butyrate-producing genera and their relationship with muscle function. Building on the background of the traditional Japanese dietary culture and longevity of the Kyotango region, this study aimed to investigate the interplay between sarcopenia and its indicators (grip strength, gait speed, and skeletal muscle volume) and the gut microbiota in an elderly cohort of Kyotango residents. Furthermore, a comprehensive dietary intake survey focusing on this unique Kyotango dietary culture was conducted. Methods Participants and sarcopenia diagnosis Faecal metagenome analysis was performed on elderly individuals aged 65 years or older who underwent community health checkups in the Kyotango area. The results were integrated with various data obtained from medical examinations conducted during health checkups to clarify the factors related to sarcopenia, faecal gut microbiota, and their relationship with diet. Sarcopenia was diagnosed based on the Asian Working Group for Sarcopenia (AWGS) diagnostic criteria, which include grip strength, gait speed, and skeletal muscle volume.6 The cut-off values for grip strength were set at 28 kg for men and 18 kg for women, and the cut-off values for gait speed were set at 1.0 m/s for both men and women.6 Skeletal muscle mass is commonly measured using dual-energy X-ray absorptiometry (DEXA) and bioelectrical impedance analysis (BIA) methods. The skeletal muscle volume in the L3 cross-section of the abdominal CT correlates well with an individual's total body skeletal muscle volume.16 Therefore, we calculated the Skeletal Muscle mass (SMI) index from abdominal CT-L3 cross-sections using the Slice Omatic® (Tomo Vision) software (Figure 1). The cut-off values of SMI were 42 cm2/m2 for men and 38 cm2/m2 for women, based on the diagnostic criteria of the Japan Society of Hepatology.16 Examples of the distribution of skeletal muscle, visceral fat, and subcutaneous fat in the L3 section of abdominal CT in a) non-sarcopenia and b) sarcopenia cases. Assessment of dietary intake A brief-type self-administered diet history questionnaire (BDHQ) was used to assess dietary and nutrient intakes.17 The raw data obtained from the BDHQ were adjusted for energy using the density method. The following nutritional components that can be calculated from the BDHQ were selected: three major nutrients (protein (animal- and plant-derived), lipids (animal- and plant-derived), and carbohydrates), vitamin D, and dietary fibre (soluble and insoluble), which are known to be associated with sarcopenia or maintenance of health.18‐22 The Japanese Diet Index (JDI) was used to calculate traditional Japanese cuisine intake.13 Based on the revised JDI−12 (r JDI−12) reported by Saji et al., we added points for rice, miso soup, seaweeds, pickles, green and yellow vegetables, fish, green tea, beans, fruits, mushrooms, and coffee, and subtracted points for beef and pork (Figure 2).23 The added and subtracted points were based on the median value of the intake of each dietary component calculated from the BDHQ, after adjusting for energy using the density method. The Japanese diet components included in r JDI−12. Analysis of gut microbiota Examination of the faecal gut microbiota was performed using the same methodology as in our previous study.24 Genomic DNA was extracted using the NucleoSpin Microbial DNA Kit (Macherey-Nagel, Düren, Germany). The 16S rRNA gene contains nine variable regions (V1-V9), of which the V3-V4 regions were amplified by polymerase chain reaction. Nucleotide sequencing was performed using the MiSeq platform (Illumina, San Diego, CA, USA). The sequence data were examined using the Quantitative Insights into Microbial Ecology 2 (QIIME 2). To process the sequence reads, the DADA2 model was employed for denoising, which resulted in the identification of amplicon sequence variants (ASV) and representative sequences.25,26 Forward and reverse reads were trimmed at the first 17 and 19 bases, respectively, and truncated at positions 260 and 240 bp according to the Phred quality profiles. Low-quality reads with expected errors >2 or Phred quality <2 were automatically filtered out, and chimeric sequences were removed using the consensus method. ASVs observed fewer than two times across all samples were discarded (singleton removal). Phylogenetic placement of ASVs was performed using SEPP against the Greengenes reference tree, and ASVs not placed in the reference tree were removed. The final denoised feature table contained a total of 25,567,099 high-quality sequences (median 65765.5 reads per sample; range 21,105–404,314). Statistical analysis Statistical analyses were performed using JMP Pro version 15.2 (SAS International Inc., Cary, NC, USA), GraphPad Prism 9.00 for Windows (GraphPad Software, La Jolla, California, USA), and SPSS software (version 25.0; IBM Japan, Ltd., Tokyo, Japan). Differences were considered statistically significant at P-value < 0.05. Data are expressed as mean ± standard deviation (SD) for continuous variables and as frequencies (percentages) for categorical variables. Comparisons between the sarcopenia and non-sarcopenia groups were made using the Mann–Whitney U test and Jonckheere-Terpstra test. Spearman’s rank correlation coefficients were calculated to examine the relationships between genus-level bacterial abundances and three muscle-related indicators: grip strength, gait speed, and skeletal muscle index (SMI). P-values were adjusted for multiple comparisons using the Benjamini–Hochberg false discovery rate (FDR) correction method. Results Diagnosis of sarcopenia In the Kyotango region, 329 elderly individuals aged ≥ 65 years underwent medical examinations between August 2017 and March 2019 (Figure 2). From this cohort, those who could not provide faecal samples or did not undergo CT were excluded; the remaining 318 participants were included. The study finally included 127 men (39.9%) and 191 women (60.1%), with an average age of 73.3 years, an average body mass index (BMI) value of 23.3 kg/m², an average maximal gait speed of 2.02 m/s, an average handgrip strength of 28.9 kg, and an average SMI of 41.8 cm²/m² (Table 1). Table 1.Background of the participants.a) Participant characteristics OverallManWomanP-valueNon-sarcopeniaSarcopeniaP-valueNumber (%)318127 (39.9)191 (60.1)-300 (94.3)18 (5.7)-Age, mean (year, min, max)73.3 (65, 101)74.1 (65, 101)72.7 (65, 89)0.16272.9 (65, 101)78.7 (68, 88)<0.001BMI, mean (kg/m2, min, max)23.3 (16.0, 38.5)23.5 (16.5, 30.5)23.2 (16.0, 38.5)0.13423.3 (16.0, 38.5)23.6 (19.7, 31.1)0.859Gait speed (m/s, mean ± SD)2.02 ± 0.402.07 ± 0.441.98 ± 0.360.0532.04 ± 0.371.64 ± 0.600.004Grip strength (kg, mean ± SD)28.9 ± 8.1036.4 ± 6.7424.0 ± 4.26<0.00129.5 ± 7.9019.4 ± 4.84<0.001SMI (cm2/m2, mean ± SD)41.8 ± 7.7747.1 ± 8.2038.2 ± 5.60<0.00142.2 ± 7.8235.7 ± 2.77<0.001b) Sex differences between sarcopenia and non-sarcopenia groups ManWoman OverallNon-sarcopeniaSarcopeniaP-valueNon-sarcopeniaSarcopeniaP-valueNumber (%)318120 (94.5)7 (5.5)-180 (94.2)11 (5.8)-Age, mean (year, min, max)73.3 (65, 101)74.0 (65, 101)74.9 (68, 85)0.58272.2 (65, 89)81.2 (70, 88)<0.001BMI, mean (kg/m2, min, max)23.3 (16.0, 38.5)23.6 (16.5, 30.5)22.6 (19.7, 25.4)0.27923.1 (16.0, 38.5)24.2 (20.4, 31.1)0.300Gait speed (m/s, mean ± SD)2.02 ± 0.402.07 ± 0.442.02 ± 0.430.9872.02 ± 0.321.39 ± 0.57<0.001Grip strength (kg, mean ± SD)28.9 ± 8.1037.0 ± 6.2824.7 ± 2.36<0.00124.5 ± 3.8616.0 ± 2.00<0.001SMI (cm2/m2, mean ± SD)41.8 ± 7.7747.9 ± 7.0737.9 ± 2.37<0.00138.4 ± 5.6934.3 ± 2.090.006 Mann–Whitney U testBMI: body mass index; SMI: skeletal muscle mass index; SD: standard deviation. Background of the participants. BMI: body mass index; SMI: skeletal muscle mass index; SD: standard deviation. Of the 318 participants, 137 exhibited a decline in muscular volume, 25 exhibited reduced grip strength, and three exhibited diminished gait speed (Figure 3). Two participants had decreased both grip strength and gait speed. Among these patients, sarcopenia was diagnosed in 18 (5.7%) patients (men 7, women 11) (sarcopenia group), whereas 300 (94.3%) patients did not have sarcopenia (non-sarcopenia group). This relatively low prevalence aligns with the overall health status of the region. However, the small sample size of the sarcopenia group may have affected the generalisability of our findings. Flowchart depicting participant recruitment in this study. There were no significant differences in age, BMI, or gait speed between men and women. However, grip strength and SMI were significantly higher in men than in women (Table 1). The age was significantly higher in the sarcopenia group than in the non-sarcopenia group. The gait speed, grip strength, and SMI were significantly lower in the sarcopenia group than in the non-sarcopenia group. There were no significant differences in age or gait speed between men in the sarcopenia and non-sarcopenia groups. In contrast, age and gait speed were significantly higher and lower, respectively, in women with sarcopenia than in those without sarcopenia. Grip strength and SMI were significantly lower in both men and women in the sarcopenia group than in those in the non-sarcopenia group. Sarcopenia-related gut microbiota The faecal gut microbiota of the sarcopenia and non-sarcopenia groups was compared. Initially, we analysed the heterogeneity of the gut microbiota within each group. Alpha diversity, evaluated using the Chao1 index, PD whole tree, and Shannon indices, did not exhibit substantial disparities between the sarcopenia and non-sarcopenia groups (Figure 4a). Similarly, considering both weighted and unweighted measures, no difference in beta diversity was observed between the sarcopenia and non-sarcopenia groups (weighted UniFrac, p = 0.797; unweighted UniFrac, p = 0.642) (Figure 4b). Presence of sarcopenia, diversity of gut microbiota, taxonomy of the gut microbiota, and significant differences in gut microbiota in participants with and without sarcopenia. a) Alpha diversity of the gut microbiota. The Chao1 index (P-value = 0.917), PD whole tree (p = 0.833), and Shannon indices (p = 0.344), did not exhibit substantial disparities between the sarcopenia and non-sarcopenia groups. b) β diversity of the gut microbiota. No difference was observed between the sarcopenia and non-sarcopenia groups (weighted UniFrac, p = 0.797; unweighted UniFrac, p = 0.642). c) Taxonomy of gut microbiota at the phylum level. d) Taxonomy of gut microbiota at the genus level. e) The sarcopenia group showed a significantly lower abundance of the genus belonging to the family Lachnospiraceae and a significantly lower abundance of the genus Megasphaera. We then analysed the taxonomy of the gut microbiota at the phylum (Figure 4c) and genus (Figure 4d) levels. Phylum Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria were the four major phyla and showed no difference in their abundances in both the sarcopenia and non-sarcopenia groups. At the genus level, 35 extractable bacteria had an occupancy rate of >0.5%. The three most abundant genera in both groups were the genus Bacteroides, Faecalibacterium, and Bifidobacterium. Furthermore, patients with sarcopenia exhibited a significantly lower abundance of an unclassified genus belonging to the family Lachnospiraceae, and a significantly higher abundance of Megasphaera (Figure 4e). Notably, Lachnospiraceae includes several butyrate-producing bacteria that have been linked to anti-inflammatory effects and energy metabolism. Gut microbiota associated with sarcopenia indicators We determined the association of gut microbiota with sarcopenia indicators (grip strength, gait speed, and SMI). The correlations (Spearman's rank correlation coefficient) between these indicators for sarcopenia diagnosis and the gut microbiota are presented in Table 2. Among the 35 genera with abundances >0.5%, we identified 10 with occupancy rates that suggested potential positive or negative correlations with grip strength, gait speed, or muscle mass. Those with a P-value ≥ 0.05 were excluded. Table 2.The correlations between sarcopenia-related diagnostic indicators and the gut microbiota.a) Correlation between grip strength and gut microbiotab) Correlation between gait speed and gut microbiotac) Correlation between muscle volume and gut microbiotaMan Man Man Positive correlationrP-valueFDR-pPositive correlationrP-valueFDR-pPositive correlationrP-valueFDR-pf__Lachnospiraceae;Other0.2710.0020.080g__Coprococcus0.2330.0090.229f__Lachnospiraceae;Other0.2190.0130.517g__Lachnospira0.1800.0430.515g__Gemmiger0.2150.0170.229 Negative correlationrP-valueFDR-pNegative correlationrP-valueFDR-pNegative correlationrP-valueFDR-pg__Streptococcus−0.1790.0440.515g__Ruminococcus−0.2130.0180.229None Woman Woman Woman Positive correlationrP-valueFDR-pPositive correlationrP-valueFDR-pPositive correlationrP-valueFDR-pNone―――g__Phascolarctobacterium0.1430.0490.794None―――Negative correlationrP-valueFDR-pNegative correlationrP-valueFDR-pNegative correlationrP-valueFDR-pg__Megasphaera−0.2110.0030.133g__Streptococcus−0.1910.0080.319 f__Lachnospiraceae;g__ −0.1600.0270.935g__Lactobacillus−0.1510.0370.523 FDR-P: False Discovery Rate-corrected p.r: Spearman's rank correlation coefficient. The correlations between sarcopenia-related diagnostic indicators and the gut microbiota. FDR-P: False Discovery Rate-corrected p. r: Spearman's rank correlation coefficient. In men, the genus Lachnospira and an unclassified genus belonging to the family Lachnospiraceae were positively correlated, while the genus Streptococcus was negatively correlated with grip strength. In women, the genera Megasphaera and Lactobacillus were negatively correlated with grip strength. Regarding gait speed, the genera Coprococcus and Gemmiger were positively correlated in men, whereas the genus Ruminococcus was negatively correlated. In women, the genus Phascolarctobacterium was positively correlated with gait speed, whereas the genus Streptococcus was negatively correlated. As for the SMI, in men, an unclassified genus belonging to the family Lachnospiraceae was positively correlated. After applying FDR correction separately for each subgroup, no genus reached the significance threshold (FDR-adjusted P < 0.05). Sarcopenia and daily food consumption We investigated the correlation between sarcopenia and the intake of each nutritional component (protein, fat, carbohydrate, vitamin D, and dietary fibre, as shown in Section 2.2) calculated from the BDHQ (energy-adjusted value). These nutritional components were not significantly different between participants with and without sarcopenia (Table 3a). Table 3.Gut microbiota correlations with nutrients and 12 Japanese dietary components.a) Association between sarcopenia and sarcopenia related nutrition (energy-adjusted value [g/day]) (mean ± SD) Nutrition (%E)Japanese average*OverallNon SarcopeniaSarcopeniaP-valueProtein [g]69.081.5 ± 18.081.8 ± 18.276.7 ± 13.90.215Animal protein37.348.7 ± 18.349.0 ± 18.443.4 ± 14.00.169Plant protein31.732.8 ± 6.232.8 ± 6.233.2 ± 6.50.940Fat [g]55.356.3 ± 12.856.4 ± 12.954.4 ± 12.20.529Animal fat28.026.7 ± 9.026.9 ± 9.024.0 ± 7.40.233Plant fat27.329.5 ± 8.229.5 ± 8.230.5 ± 8.10.733Carbohydrate [g]235.3261.6 ± 40.4260.9 ± 40.7272.4 ± 34.70.311Vitamin D [μg]8.222.2 ± 13.122.3 ± 13.120.0 ± 11.90.372Total dietary fibre [g]19.814.4 ± 4.314.4 ± 4.314.1 ± 3.90.795Soluble dietary fibre4.03.6 ± 1.23.6 ± 1.23.5 ± 1.10.911Insoluble dietary fibre13.010.2 ± 2.910.2 ± 2.910.0 ± 2.70.850 Mann–Whitney U testb) Association between sarcopenia and amount of Japanese diet intake (energy-adjusted value [g/day]) (mean ± SD) Japanese diet [g] (%E)Japanese average**OverallNon SarcopeniaSarcopeniaP-valueRice139.3290.7 ± 143.2290.5 ± 142.9295.3 ± 152.30.742Miso soupー179.7 ± 154.9180.8 ± 156.7162.3 ± 124.10.728Seaweeds2.117.7 ± 16.017.8 ± 16.314.9 ± 9.30.961Picklesー49.2 ± 35.648.7 ± 35.457.6 ± 38.30.153Green and yellow vegetables71.7117.1 ± 72.1117.1 ± 72.5116.1 ± 66.80.991Green Teaー284.5 ± 295.1286.6 ± 292.0250.2 ± 352.30.269Beans24.686.1 ± 58.687.0 ± 58.771.8 ± 57.70.187Fish60.3106.3 ± 58.9106.9 ± 59.197.0 ± 56.10.359Fruits90.9161.1 ± 110.9161.5 ± 113.1154.4 ± 65.70.795Mushroom9.413.7 ± 12.213.8 ± 12.111.8 ± 12.80.399Coffee230.6***250.2 ± 186.7250.2 ± 188.7251.7 ± 153.50.717Beef and pork52.830.2 ± 21.630.1 ± 21.733.2 ± 19.60.392r JDI−12ー6.0 ± 2.06.0 ± 0.15.7 ± 2.00.559 Mann–Whitney U test*The National Health and Nutrition Survey in Japan, 2019, Ministry of Health, Labour and Welfare.**Food supply and demand chart, 2022, Ministry of Agriculture, Forestry and Fisheries.***Basic Survey on Coffee Demand Trends, 2020, National Coffee Roasters Association of Japan. Gut microbiota correlations with nutrients and 12 Japanese dietary components. The National Health and Nutrition Survey in Japan, 2019, Ministry of Health, Labour and Welfare. Food supply and demand chart, 2022, Ministry of Agriculture, Forestry and Fisheries. Basic Survey on Coffee Demand Trends, 2020, National Coffee Roasters Association of Japan. Upon investigating the Japanese diet consumption calculated using r JDI−12, we identified some features of the intake pattern in the Kyotango area. Compared to the Japanese average, the Kyotango area exhibited a higher consumption of seaweed, fish, beans, vegetables, and fruits, whereas meat intake was notably low (Table 3b).27‐29 There was no significant difference in the frequency of Japanese dietary intake between the sarcopenia and non-sarcopenia groups. The r JDI−12 was slightly lower in the sarcopenia group than in the non-sarcopenia group; however, the difference was not statistically significant (sarcopenia group: non-sarcopenia group = 5.7:6.0, p = 0.56). Nutritional and food factors associated with sarcopenia-related gut microbiota Hierarchical cluster analysis was performed to examine the relationship between the 10 genera associated with sarcopenia indicators (Table 2) and the 11 nutritional components calculated using the BDHQ (Figure 5a), as well as the consumption of the 12 Japanese dietary components (Figure 5b). Bray-Curtis dissimilarity was calculated from relative abundance data and used for hierarchical clustering. The heatmap displays the relative abundance of each genus across samples, clustered by microbiota similarity. We found that several genera, namely, Coprococcus, Lachnospira, an unclassified genus belonging to the family Lachnospiraceae, and Gemmiger were categorised as clusters that were positively correlated with nutritional components, especially protein, vitamin D, and dietary fibre (Figure 5a). The gut microbiota, which consisted of clusters that were positively correlated with each r JDI−12 component, was the same as the clusters that were positively correlated with nutrients associated with sarcopenia. Among these genera, Coprococcus —a representative butyrate-producing genus—, which was positively correlated with grip strength and gait speed, showed a significant positive correlation with the r JDI−12 score (Figure 5b). Hierarchical cluster analysis depicting a) the relationship between microbiota and nutrient intake, and b) the relationship between gut microbiota and 12 Japanese dietary components. Bray-Curtis dissimilarity was calculated from relative abundance data and used for hierarchical clustering. The heatmap displays the relative abundance of each genus across samples, clustered by microbiota similarity. Genus Coprocossus and the intake of Japanese dietary components We assessed the association between the genus Coprococcus and the nutritional and Japanese dietary components using cluster analysis. The abundance of the genus Coprococcus was divided into quartiles, and the association with each nutrient or the Japanese diet (energy-adjusted value [g/day]) was analysed using the Jonckheere-Terpstra test (Table 4). The consumption of animal and plant proteins (p = 0.024 and p = 0.043, respectively), animal fat (p = 0.045), vitamin D (p = 0.014), and both soluble and insoluble dietary fibre (p = 0.002 and p < 0.001, respectively) was associated with a significant monotonic increase in the abundance of the genus Coprococcus (Table 4a). Furthermore, 12 Japanese dietary components, including seaweed (p = 0.006), beans (p = 0.01), fish (p = 0.021), green and yellow vegetables (p = 0.030), and mushrooms (p = 0.048), were associated with a significant monotonic increase in the abundance of Coprococcus, in addition to r JDI−12 (p = 0.001) (Table 4b). Table 4.Associations of Coprococcus abundance with nutrients and 12 Japanese dietary components.a) Genus Coprococcus and the intake of each nutrition (energy-adjusted value [g/day]) (median ± SD) Trend testg__Coprococcus P-valueQ1Q2Q3Q4 0.0000−0.01790.0180−0.03140.0315−0.05310.0532−0.1900Protein 0.006 76.9 ± 16.480.2 ± 16.684.4 ± 21.484.4 ± 16.2Animal protein 0.024 44.3 ± 16.347.5 ± 16.352.5 ± 22.050.3 ± 17.0Plant protein 0.043 32.6 ± 5.832.7 ± 7.732.0 ± 7.734.1 ± 5.1Fat0.41256.2 ± 13.955.5 ± 12.756.0 ± 12.757.3 ± 12.1Animal fat 0.045 25.5 ± 9.025.8 ± 8.527.7 ± 9.627.9 ± 8.7Plant fat0.34030.7 ± 8.429.8 ± 8.628.3 ± 7.129.4 ± 8.7Carbohydrate0.940264.1 ± 40.8257.8 ± 41.5262.5 ± 42.2262.0 ± 37.4Vitamin D 0.014 18.5 ± 8.922.0 ± 12.024.8 ± 16.923.5 ± 12.4Total dietary fibre <0.001 13.6 ± 4.614.0 ± 4.314.1 ± 3.915.8 ± 4.0Soluble dietary fibre 0.002 3.4 ± 1.33.5 ± 1.33.5 ± 1.14.0 ± 1.1Insoluble dietary fibre <0.001 9.7 ± 3.210.0 ± 3.09.9 ± 2.611.2 ± 2.7 Jonckheere-Terpstra testb) Genus Coprococcus and the intake of each dietary item of the Japanese diet (energy-adjusted value [g/day]) (median ± SD) Trend testg__Coprococcus P-valueQ1Q2Q3Q4 0.0000−0.01790.0180−0.03140.0315−0.05310.0532−0.1900r JDI−12 0.001 5.6 ± 2.05.8 ± 2.16.0 ± 1.76.6 ± 1.9Rice0.437288.7 ± 159.4278.4 ± 135.9304.7 ± 139.2291.1 ± 138.6Miso soup0.205178.7 ± 136.7159.6 ± 149.5151.3 ± 114.1229.8 ± 198.1Seaweeds 0.006 14.1 ± 11.715.6 ± 13.021.1 ± 21.619.9 ± 15.1Pickles0.45548.4 ± 33.251.3 ± 41.647.2 ± 33.250.1 ± 34.2Green and yellow vegetables 0.030 107.1 ± 70.4119.5 ± 77.5111.2 ± 66.1130.8 ± 73.0Fish 0.021 93.1 ± 47.1103.1 ± 50.5120.5 ± 78.2108.6 ± 52.2Green Tea0.052306.3 ± 357.2215.3 ± 238.0297.7 ± 292.6319.4 ± 275.0Beans 0.010 76.7 ± 59.890.8 ± 65.881.9 ± 50.795.0 ± 56.6Fruits0.059146.8 ± 117.7168.4 ± 112.4154.3 ± 92.2175.0 ± 119.5Mushrooms 0.048 13.0 ± 12.512.8 ± 12.414.1 ± 12.215.1 ± 11.7Coffee0.472256.9 ± 212.4239.7 ± 150.7246.9 ± 166.6257.7 ± 212.6Beef and pork0.29629.1 ± 19.228.9 ± 20.030.1 ± 20.933. ± 25.9 Jonckheere-Terpstra test Associations of Coprococcus abundance with nutrients and 12 Japanese dietary components. Discussion In this study, we investigated the interplay between sarcopenia, intake of the Japanese diet, and gut microbiota in a cohort of elderly individuals from the Kyotango region, recognised for their healthy longevity in Japan.15 To the best of our knowledge, this is the first report to clarify the association between gut microbiota and sarcopenia based on an analysis of Japanese dietary intake targeting a longevity region. The results of this study suggest that the abundance of bacteria associated with sarcopenia indicators is linked to Japanese dietary habits. In particular, several butyrate-producing genera belonging to the family Lachnospiraceae are key bacteria for sarcopenia prevention. Compared to prior studies, which mainly reported a reduced abundance of butyrate-producing bacteria in sarcopenic individuals, our study is unique in targeting a longevity region with distinct dietary traditions. By focusing on a region characterised by high consumption of traditional Japanese foods, our findings provide novel insights into host–microbiome interactions in healthy aging populations. Specifically, our results showed that the abundance of an unclassified genus belonging to the family Lachnospiraceae was significantly lower and that of the genus Megasphaera was significantly higher in the sarcopenia group than in the non-sarcopenia group. The family Lachnospiraceae contains several butyrate-producing genera, including Coprococcus and Lachnospira. Coprococcus was positively correlated with gait speed, whereas Lachnospira had a weak positive correlation with grip strength in men. Although many of the correlations between gut microbiota and muscle-related indicators were relatively weak and lost statistical significance after FDR correction, a certain trends were observed. The genus Megasphaera, the abundance of which increased in the sarcopenia group, is known to increase in athletes with low muscle strength and performance30 as well as in individuals with chronic inflammatory diseases, such as nonalcoholic hepatitis and genitourinary tract inflammation, and may be associated with the production of high levels of lipopolysaccharides.31,32 Regarding the relationship between dietary components and gut microbiota, our study established that consumption of the traditional Japanese diet in the healthy non-sarcopenia group resulted in an abundance of certain gut microbiota. Compared with the non-sarcopenia group, the sarcopenia group consumed the Japanese diet slightly less frequently; however, the difference in intake between the two groups was not significant. Hierarchical cluster analysis of Japanese food components and gut microbiota showed that the genera in the cluster with a high frequency of Japanese diet intake were primarily genera belonging to the family Lachnospiraceae and were consistent with the genera that showed a positive correlation with grip strength, gait speed, and SMI. These butyrate-producing bacteria were also positively correlated with protein, vitamin D, and dietary fibre intake in a hierarchical cluster analysis of nutritional components and gut microbiota. Although the aetiology of sarcopenia remains unclear, a recent study has reported that dysbiosis allows inflammatory compounds of bacterial origin to enter the circulatory system and affect muscle metabolism.33 In animal studies, germ-free mice showed a decrease in skeletal muscle volume and muscle strength, while faecal microbial transplantation restored muscle mass in these mice.34 In addition, short-chain fatty acids, metabolites of the gut microbiota, have been reported to upregulate protein biosynthesis by activating the mTOR signalling pathway, thereby enhancing muscle volume and function,35 suggesting that several butyrate-producing bacteria are associated with sarcopenia and sarcopenia-related factors. We also found that the abundance of butyrate-producing bacteria in faeces was higher in those who consumed the Japanese diet more frequently. Recently,Han et al. revealed that butyrate concentration in faeces is significantly correlated with skeletal muscle volume in humans,supporting our results.11 Butyrate, a histone deacetylase inhibitor, reduces age-related muscle atrophy, oxidative stress, and intramuscular fat accumulation in mouse models.36 It also promotes regulatory T cell production, exhibits anti-inflammatory effects, and may help suppress hypercatabolism in sarcopenia.37 Additionally, exercise has been linked to increased levels of butyrate-producing bacteria, while a lack of exercise reduces these bacteria and restores the gut microbiota to its original state.38 The type of dietary intake that helps to prevent sarcopenia remains a key consideration. Adequate protein intake has been recognised to prevent sarcopenia in the elderly owing to their reduced protein sensitivity and synthesis capacity.18,19,39 However, we found no significant difference in protein intake between patients with and without sarcopenia. The gut microbiota-mediated effects of a high-protein diet are not always favourable for muscles.40,41 Mice fed a high-protein diet showed decreased Firmicutes/Bacteroides ratio and expense of gut microbiota that produce metabolic modulators such as short-chain fatty acids.42 Furthermore, it increases the abundance of pathogenic bacteria such as Enterobacteriaceae, leading to negative effects on muscle metabolism, such as the induction of inflammation and increased insulin resistance. Similar results have been obtained in human randomised controlled trials, where long-term administration of beef protein supplements to athletes reduced the abundance of beneficial faecal microbiota taxa, such as the genera Bifidobacterium, Roseburia, and Blautia.43 Notably, our study revealed that the abundance of the genus Coprococcus, which was positively correlated with physical function, was significantly correlated with the Japanese dietary components of seaweeds, beans, fish, green and yellow vegetables, and mushrooms. Fish and beans are rich in proteins and are known to increase butyrate-producing bacteria.44 Furthermore, taurine in fish and isoflavones in soybeans contribute to longevity.45 Our study revealed that healthy elderly Kyotango people tend to consume more fish and beans and limit their meat consumption. Therefore, appropriate intake of high-quality protein in the Japanese diet may prevent sarcopenia. Despite these intriguing findings, our study had some limitations. First, because the Kyotango area is a region with a long life and good health, the number of people with sarcopenia was very low. Hence, owing to the small number of sarcopenia cases, the statistical power and generalisability were limited. Second, this was a cross-sectional study of older adults who underwent physical examinations at a single region in Japan. Due to the potential for selection bias, geographic considerations should be considered for generalisation. Third, the metabolites produced by intestinal bacteria, including short-chain fatty acids, were not measured, and it is unclear whether the levels of butyrate and other short-chain fatty acids truly increased. Despite these limitations, our findings are exploratory and provide preliminary evidence that certain bacteria, such as Coprococcus and Lachnospiraceae, might be associated with preserved muscle function in the elderly. Future longitudinal and interventional studies are needed to confirm these findings and explore the potential causal relationships between diet, gut microbiota, and risk of sarcopenia. In conclusion, our findings suggest that consumption of the traditional Japanese diet may contribute to the prevention of sarcopenia by increasing the abundance of butyrate-producing bacteria, mainly genera belonging to the family Lachnospiraceae. Author contributions Conception and design of the study: Takeshi Yasuda. Acquisition, analysis, and interpretation of data: Takeshi Yasuda, Tomohisa Takagi, Ryo Inoue, Katsura Mizushima, Kouhei Asaeda, Hikaru Hashimoto, Hiroaki Kitae, Kazuhiko Uchiyama, Norihiro Ouchi, Atsuo Adachi, Tadaaki Kamitani, Yuji Naito, Satoaki Matoba, and Yoshito Itoh. Draughting of the manuscript: Takeshi Yasuda and Tomohisa Takagi. Critical revision for important intellectual content: Tomohisa Takagi and Yuji Naito. Final approval of the manuscript: Takeshi Yasuda, Tomohisa Takagi, Ryo Inoue, Yuji Naito, Satoaki Matoba, and Yoshito Itoh. Disclosure of potential conflicts of interest Tomohisa Takagi received collaborative research funds from Mitsubishi Tanabe Co., Ltd. and PreMedica, Inc. and lecture fees from Mochida Pharma Co., Ltd., Janssen Pharmaceutical K.K., and Mitsubishi Tanabe Co., Ltd. Yuji Naito received scholarship funds from EA Pharma Co. Ltd., collaboration research funds from Taiyo Kagaku Co. Ltd., and lecture fees from Mylan EPD Co. and Takeda Pharma. Co., Ltd., and Mochida Pharma. Co. Ltd., EA Pharma. Co., Ltd. and Otsuka Pharma, Japan. Co. Ltd., and Miyarisan Pharma. Co. Ltd. Yoshito Itoh is affiliated with a department funded by donations from Nichinichi Pharmaceutical Co. Ltd. This study was partially supported by these funds. Neither the funding agencies nor any other organisations participated in the study design nor had any competing interests. All companies approved the final version of the manuscript. Data availability statement The data generated in this study are deposited in the Sequence Read Archive (SRA) of the NCBI database with accession number PRJNA914797 and are available from February 28, 2023. Ethical guidelines statement This study was approved by the Kyoto Prefectural University of Medicine Medical Ethics Review Committee, and informed consent was obtained from all participants (approval number: ERB-C−885−4). This study was conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its subsequent amendments. All participants provided informed consent before their inclusion in the study. Clinical trial number Not applicable. References Associated Data Data Availability Statement The data generated in this study are deposited in the Sequence Read Archive (SRA) of the NCBI database with accession number PRJNA914797 and are available from February 28, 2023.